Crossbow Therapeutics is a Biotech company based in Cambridge. It has raised $80M in total funding. Latest round: Series A.
Crossbow Therapeutics is a Biotech company based in Cambridge. Crossbow Therapeutics has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2023. The round record for Crossbow Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include MPM BioImpact, Pfizer Ventures. 2 distinct backers are named across the disclosed rounds.
Crossbow Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Cambridge below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026